Stanford neuroscientist translating lab and clinical science into protocols for sleep, focus, exercise, mental health, and longevity.

Entrepreneur/self-experimenter (Blueprint); shares biomarker-driven protocols and results.

Veteran biotech journalist; delivers breaking industry news and analysis at STAT News.

Biotech investor; shares deep dives on biotech companies and investment strategies (often covering stocks he holds).

Yale immunologist; translational immunology/virology

Sr. Business Editor, GEN/GEN Edge; biotech business

Insilico Medicine founder; posts AI drug discovery and aging research developments.

Stay informed with the latest from AllFamilyPharmacy.com — including exclusive discounts, new medication announcements, wellness tips, and important...

Senior biopharma correspondent, Endpoints

Biomedicine editor at MIT Technology Review; covers cutting-edge biotech breakthroughs and their societal impact.

Senior Editor, BioPharma Dive

Director, The Medical Futurist Institute; digital health educator

Co-founder, NaviMed Capital; health services IT

Biotech investment educator; former biotech executive and banker sharing insights and lessons for investing in the sector.

Bloomberg’s markets channel; home to ETF IQ episodes; ETF trends/flows coverage.

Pseudonymous biotech insider; provides daily biotech news, startup financing updates, and trend analysis.

Biotech investor; creator of biotech stock indices and commentator on market trends.

Biotech venture capitalist (Atlas Venture); blogs as 'LifeSciVC' sharing startup trends and industry analysis.

📌Top 22 Women in Tech and Influencers to Follow 2022. #Tech #AI #ML #Data, #Cybersec, #GenAI, #ChangeManagement, #Careeradvice,...

Entrepreneur/investor; atai Life Sciences; psychedelics and mental health

STAT reporter-at-large on biopharma industry

STAT Washington correspondent on health policy

Serial biotech entrepreneur; founded PureTech Health and co-founded Karuna Therapeutics, now CEO of Seaport Therapeutics.

Clinician focused on prevention/longevity; curates aging science and protocols.

Harvard/Broad Institute professor; pioneer of CRISPR gene editing (base and prime editing) driving biotech innovation.

Harvard geneticist; posts research, analyses, and interviews on aging biology and interventions.

Join the private membership of Dr. Mercola's Censored Library today to begin accessing must-read information you won't find...

Executive Editor, Endpoints; policy/FDA/industry

Cardiologist and digital medicine researcher; leading voice on biotech and healthcare innovation.

End Times headline news. Research and analysis of world events in light of Bible prophecy.

Investigative scholarship and reporting of public policy, health, justice, and current affairs.

Biostatistician; trial design/analysis, reproducible methods

Yale cardiologist/outcomes researcher; trials, RWE

Senior infectious disease reporter at STAT News; renowned for authoritative coverage of outbreaks, vaccines, and public health.

GMP, manufacturing, quality and compliance for pharma/biotech.

Biotech journalist (focus on oncology); provides sharp analysis of cancer drug data and industry developments.

Chair, Computational Biomedicine at Cedars-Sinai; AI/biostats

Co-founder & CEO of Ginkgo Bioworks; leading voice in synthetic biology and biotech entrepreneurship.

Veteran biotech journalist; founder of Endpoints News and known for insider industry insights.

Founder, SynBioBeta; community + events for synthetic biology

Academic health system; care delivery and innovation.

Senior reporter, BioPharma Dive; pipelines/business

Psychiatrist and author; psychopharmacology, mental health, and psychedelic research

Author/editor (CRISPR, genomics); biotech education

Interviews and insights across pharma, biotech and medtech sectors.

BioViva founder; posts gene therapy and regenerative medicine topics.

Biotech journalist and author; founder of the Timmerman Report, offering deep industry coverage and analysis.

Journalist/analyst who has examined pharma vs. wellness industry scale, regulation, and market dynamics.

Academic hospital; research, quality and delivery.

Senior biotech journalist at STAT News; covers drug development and the human stories behind the science.

Psychopharmacology researcher (JHU); psychedelics and behavior

Global medtech event and media channel featuring interviews and segments across medical devices, digital health, and health innovation.

Oncologist/clinical researcher; trial commentary

Bioinformatics director at AstraZeneca; science communicator who teaches genomics (YouTube channel 'Chatomics').

U.S. government’s medical research agency; features research advances, policy, and interviews across 27 institutes and centers.

The official YouTube presence of the journal Nature, featuring high-quality videos about cutting-edge scientific research. Many episodes highlight...

Unveiling the science behind natural remedies

New England Journal of Medicine group channel featuring procedural videos, research explainers, and new journals like NEJM AI.

Oxford PhD and Harvard MD focused on metabolism, cardiometabolic risk, brain aging, and nutrition science.

Gene therapy scientist; AAV and gene editing expert sharing lab breakthroughs and industry updates in advanced therapeutics.

Founder/CEO Flagship Pioneering; Co-founder/Chair, Moderna

Biotech venture investor; immunology/oncology focus

Co-founder/CSO Aleta Biotherapeutics; I/O biology/CMC

Exec. Chairman @XPRIZE @fountainlife_hq (and others) Working to extend human healthspan.

Vaccine scientist and pediatrician; leads efforts in tropical disease vaccines and fights anti-science misinformation.

Biotech venture capitalist (RA Capital); scientist and author shaping industry investment strategies.

Biotech investor/entrepreneur; small-cap biotech analysis

Your Weekly Dose of Leadership. The "Pharma Leaders" offers a weekly newsletter dedicated to providing actionable insights, tools,...

Japan’s PMDA training and regulatory updates (GCP/GLP/GMP, clinical trial and approval pathways).

CEO interviews and market news for LSE/AIM & Europe

Radically Genuine exposes the ugly truth behind psychiatric diagnoses, medications, and therapy culture that create lifelong patients. If...

Managing Partner, Planetary VC; clean energy investor; author; SingularityU Energy & Environment co‑chair

Academic physician; covers prevention/longevity, population health, and health‑innovation trends.

Co-founder of ARCH Venture Partners; influential biotech VC behind numerous startups and known for bold industry bets.

Neuroscientist; psychedelic science; consciousness and therapeutic mechanisms.

Tech educator; AI/IoT/5G intersections.

Founder/CEO Wild Earth; biotech entrepreneur & investor

Oncology consultant and blogger; author of PharmaStrategy Blog known for insightful analysis of cancer drug development.

Physician-author who engages on medical evidence, ethics, and oversight; participates in discussions intersecting with regulation and pharma.

Neuroscientist and science communicator; posts evidence-based commentary on vaccines, EBM, and health regulation alongside biotech discussions.

Physician and former FDA Commissioner; influential voice on biotech regulation and public health (board member at Pfizer &...

Co-founder & CEO, Octant Bio; multiplexed drug discovery

Academic medicine; innovation, care delivery, outcomes.

Biopharma/medtech policy and industry news, explainers, interviews.

Narrated features and news roundups from Drug Discovery World covering discovery, development, enabling tech, and industry trends.

Authoritative insight on politics, business & finance.

The latest news and exclusive analysis across the FDA-regulated industries from former FDA professionals and industry experts. Save...

Investor at Pillar VC; co-founder Petri; biotech startups

Official FDA channel covering regulatory science, approvals, safety, and industry guidance (CDER/CBER content, SBIA, Grand Rounds).

General Partner, a16z Bio + Health; comp bio/AI in drug dev

Macro strategist posting on USD/rates/PMIs that directly affect cross‑commodity pricing across energy, metals, and agriculture.

Digital health investor (Draper Esprit/Octopus); AI, contact tracing

UK small & mid caps, market news, CEO insights

UK private investor; active UK/European small/mid‑cap commentary, trade notes and educational posts.

Global health systems, regulations, and policy.

Live market coverage and interviews on rates, currencies, and macro investing.

Biotech and pharma commentator; focuses on gene editing, CRISPR and biotech market analysis for investors.

Sr. Editor, Endpoints; FDA/Capitol Hill/biopharma